US20040102835A1 - Flexible expandable stent - Google Patents

Flexible expandable stent Download PDF

Info

Publication number
US20040102835A1
US20040102835A1 US10/644,465 US64446503A US2004102835A1 US 20040102835 A1 US20040102835 A1 US 20040102835A1 US 64446503 A US64446503 A US 64446503A US 2004102835 A1 US2004102835 A1 US 2004102835A1
Authority
US
United States
Prior art keywords
stent
curve
cells
inside
loops
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/644,465
Inventor
Henry Israel
Gregory Pinchasik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinol Ltd
Original Assignee
Medinol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US08/213,272 priority Critical patent/US5449373A/en
Priority to US28218194A priority
Priority to US08/457,354 priority patent/US5733303A/en
Priority to US78246797A priority
Priority to US08/881,594 priority patent/US5843120A/en
Priority to US09/026,099 priority patent/US5972018A/en
Priority to US09/337,629 priority patent/US6461381B2/en
Priority to US09/971,616 priority patent/US6635084B2/en
Application filed by Medinol Ltd filed Critical Medinol Ltd
Priority to US10/644,465 priority patent/US20040102835A1/en
Assigned to MEDINOL, LTD. reassignment MEDINOL, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ISRAEL, HENRY MARSHALL, PINCHASIK, GREGORY
Publication of US20040102835A1 publication Critical patent/US20040102835A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27556073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040102835(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped

Abstract

A stent for implanting in the body to hold open a blood vessel includes cells with facing loops and the curved flexible links disposed and adapted to cooperate so that, when unexpended, the stent can flex as it is moved through curved blood vessels to a site where it is to be expanded and so that, when the stent is expanded in a curved vessel, at that site, as compared to each other, cells on the outside of the curve are open in length, but narrow in width as compared to cells on the inside of the curve which are short in length but increased in width to result in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur causing the stent, when coated with a medicine, to apply a more even dose to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area.

Description

    RELATED APPLICATIONS
  • This application is a continuation of Ser. No. 09/337,629 filed Jun. 21, 1999, which is a continuation of Ser. No. 09/026,099 filed Feb. 19, 1998 (now U.S. Pat. No. 5,972,018), which is a continuation of Ser. No. 08/881,594 filed Jun. 24, 1997 (now U.S. Pat. No. 5,843,120), which is a continuation of Ser. No. 08/782,467 filed Jan. 10, 1997, now abandoned, which is a continuation of Ser. No. 08/457,354, filed May 31, 1995 (now U.S. Pat. No. 5,733,303), which is a continuation of Ser. No. 08/282,181 filed Jul. 28, 1994 (now abandoned) and a continuation-in-part of Ser. No. 08/213,272, filed Mar. 17, 1994 (now U.S. Pat. No. 5,449,373).[0001]
  • FIELD OF THE INVENTION
  • The present invention relates generally to stents for implanting into a living body. [0002]
  • BACKGROUND OF THE INVENTION
  • Various stems are known in the art wherein, for the present application, the term “stent” indicates a device, made of body-compatible material, which is utilized to widen a blood vessel, or other orifice in the body, and to maintain the resultant size of the lumen. Typically, the stent is delivered to the desired location in the body with an inflatable balloon and, when the balloon is inflated, the stem expands, thereby widening the orifice. Other mechanical devices which cause expansion of the stent are also utilized. [0003]
  • Exemplary patents in the field of stents formed of wire are: U.S. Pat. No. 5,019,090 to Pinchuk, U.S. Pat. No. 5,161,547 to Tower, U.S. Pat. No. 4,950,227 to Savin, et al., U.S. Pat. No. 5,314,472 to Fontaine, U.S. Pat. No. 4,886,062 and U.S. Pat. No. 4,969,458 to Wiktor and U.S. Pat. No. 4,856,516 to Hillstead. Stems formed of cut stock metal are described in: U.S. Pat. No. 4,733,665 to Palmaz, U.S. Pat. No. 4,762,128 to Rosenbluth, U.S. Pat. No. 5,102,417 to Palmaz and Schatz, U.S. Pat. No. 5,195,984 to Schatz and WO 91FR013820 to Meadox. [0004]
  • The stents described in U.S. Pat. No. 5,102,417 to Palmaz and Schatz have expandable tubular grafts connected together with a flexible connector. The grafts are formed of a plurality of slots disposed parallel to the longitudinal axis of the tube. The flexible connectors are helical connectors. Since the tubular grafts are relatively rigid, the flexible connectors are needed so that the stents can bend when being fed through a curved blood vessel. When the stents of U.S. Pat. No. 5,102,417 expand, the grafts expand radially and, consequently, shrink longitudinally. However, at the same time, the helical connectors twist. The twisting motion is most probably harmful to the blood vessel. [0005]
  • U.S. Pat. No. 5,195,984 to Schatz describes a similar stent but with one straight connector, parallel to the longitudinal axis of the tubular grafts, between tubular grafts. The straight member removes the twisting motion; however, it is not a very strong connector. [0006]
  • SUMMARY OF THE PRESENT INVENTION
  • In accordance with embodiments of the present invention, a stent for implanting in the body to hold open a blood vessel, includes a body-compatible metal mesh defining a tube having adjacent contiguous cells, the cells having walls which are also the walls of adjacent cells. Each of the plurality of cells includes a pair of facing loops, each facing loop having a curved apex generally aligned along the longitudinal axis. Each facing loop has a first end and a second end that are generally aligned along the circumferential axis, each of the facing loops adapted to open further upon radial expansion of the stent which tends to foreshorten the stent longitudinally. Each of the plurality of cells further includes a pair of curved flexible links which connect the adjacent ends of the pair of facing loops to complete each of the plurality of cells, the pair of curved flexible links made of a metal which, upon expansion of the stent, bend to substantially offset foreshortening along the longitudinal axis. [0007]
  • The pair of facing loops and the curved flexible links are disposed and adapted to cooperate so that the tube, when unexpended, can flex as it is moved through curved blood vessels to a site where it is to be expanded and so that, when the stent is expanded in a curved vessel, at that site, as compared to each other, cells on the outside of the curve are open in length, but narrow in width as compared to cells on the inside of the curve which are short in length but increased in width. This results in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur. Consequently, when the stent is coated with a medicine the compensation results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area[0008]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention will be understood and appreciated more fully from the following detailed description taken in conjunction with the drawings in which: [0009]
  • FIG. 1 is an illustration of a patterned stent, constructed and operative in accordance with a first preferred embodiment of the present invention; [0010]
  • FIG. 2 is an illustration of the pattern of the stent of FIG. 1; [0011]
  • FIG. 3 is an illustration of the stent of FIG. 1 in a bent position; [0012]
  • FIG. 4 is an illustration of the stent of FIG. 1 in an expanded format; [0013]
  • FIGS. 5A and 5B are illustrations of the changes in the patterns of the stent of FIG. 1 due to expansion; [0014]
  • FIG. 6 is a schematic illustration of a second embodiment of the pattern for a stent; [0015]
  • FIG. 7 is an illustration of a third embodiment of the pattern for the stent; and [0016]
  • FIG. 8 is an illustration of the pattern of FIG. 7 in an expanded format.[0017]
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • Reference is now made to FIGS. [0018] 1-4 which illustrate a first embodiment of a stent, constructed and operative in accordance with the principles of the present invention. FIG. 1 illustrates the stent in its non-expanded form, FIG. 2 illustrates the pattern of the stent, FIG. 3 illustrates it in a partially bent position and FIG. 4 illustrates it in an expanded form. As shown in FIG. 3, the stent 30 defines a longitudinal aperture 80 having a longitudinal axis or longitudinal extension 79.
  • The stent of the present invention is a tube whose sides are formed into a plurality of each of two orthogonal meander patterns which patterns are intertwined with each other. The term “meander pattern” is taken herein to describe a periodic pattern about center line and “orthogonal meander patterns” are patterns whose center lines are orthogonal to each other. [0019]
  • In the stent of FIGS. [0020] 1-4, the two meander patterns are labeled 11 and 12 and they are most easily seen in FIG. 2. Meander pattern 11 is a vertical sinusoid having a vertical center line 9. Meander pattern 11 has two loops 14 and 16 per period wherein loops 14 open to the right while loops 16 open to the left. Loops 14 and 16 share common members 15 and 17, where member 15 connects from one loop 14 to its following loop 16 and member 15 connects from one loop 16 to its following loop 14.
  • Meander pattern [0021] 12 is an horizontal pattern having an horizontal center line 13. Meander pattern 12 also has loops, labeled 18 and 20, but between loops of a period is an extended straight section labeled 22. Loops 18 open downwards and loops 20 open upwards.
  • Vertical meander pattern [0022] 11 is provided in odd and even (o and e) versions which are 180° out of phase with each other. Thus, each left opening loop 16 of meander pattern 11 o faces a right opening loop 14 of meander pattern 11 e and a right opening loop 14 of meander pattern 11 o faces a left opening loop 16 of meander pattern 11 e.
  • Horizontal meander pattern [0023] 12 is also provided in odd and even forms. The straight sections 22 of horizontal meander pattern 12 e intersect with every third common member 17 of vertical meander pattern 11 e. The straight sections 22 of horizontal meander pattern 12 o intersect with every third common member 15 of vertical meander pattern 11 e, beginning with the common member 15 two after an intersected common member 17. The result is a full loop 14 between meander patterns 12 e and 12 o and a full loop 16 between meander patterns 12 o and 12 e.
  • Returning to FIG. 1, the pattern of FIG. 2 is formed into a tube [0024] 30 of an easily deformable material, such as a metal. Due to the two meander patterns, the stent of FIG. 1, when attached over a catheter balloon, is flexible and can therefore be easily dragged through curved blood vessels. An example of the way in which the stent of FIG. 1 bends is illustrated in FIG. 3.
  • In FIG. 3, the stent begins to bend at the point marked A in the direction marked by arrow [0025] 40. As the stent begins to curve, the section marked I becomes the inside of the curve while the section marked O becomes the outside of the curve. The inside of the curve I is shortened vis-a-vis the outside of the curve O.
  • During bending, the loops [0026] 14-20 to the right of the point A change shape in order to compensate for the differences in length between the inside and outside curves. For example, loops 18 i and 20 i near the inside of the curve are closer together than loops 18 o and 20 o on the outside of the curve, which expand. Loops 14 i and 16 i near the inside I are compressed while the loops 14 o and 16 o closer to the outside O of the curve are expanded.
  • As can be seen, both meander patterns [0027] 11 and 12 are involved in the bending. Although not shown, it will be appreciated that the stent of FIGS. 1-4 can bend in any direction and in more than one direction at any time.
  • FIG. 4 illustrates the stent of FIG. 1 in its expanded form. When the stent expands, both meander patterns [0028] 11 and 12 expand (i.e. all loops 14-20 open up). As can be seen, the expanded stent has two types of enclosed spaces, a large space 42 between meander patterns 12 o and 12 e and a small space 44 between meander patterns 12 e and 12 o. As can also be seen, each large space 42 has two loops 14 on its left side and two loops 16 on its fight side. The large spaces between vertical meander patterns 11 e and 11 o, which are labeled 42 a, have loops 18 at their tops and bottoms while the large spaces between vertical meander patterns 11 o and 11 e, which are labeled 42 b, have loops 20 at their tops and bottoms. Similarly for small spaces 44 a and 44 b.
  • It is noted that, due to the orthogonal meander patterns [0029] 11 and 12, the stent of FIG. 1 does not significantly shrink during expansion. This is illustrated in detail in FIGS. 5A and 5B to which reference is now made. FIG. 5A illustrates the movement, during expansion, of one vertical meander pattern 11 and FIG. 5B illustrates the movement, during expansion, of one horizontal meander pattern 12. The original patterns are shown with solid lines and the expanded patterns are shown with dashed lines.
  • The vertical meander pattern [0030] 11 of FIG. 5A expands by widening its loops 14 and 16. As a result, the vertical meander pattern 11 grows vertically by an amount 2*h1 per loop. However, it also shrinks horizontally, by an amount 2*d1. Similarly, the horizontal meander pattern 12 of FIG. 5B expands by widening its loops 18 and 20. As a result, the horizontal meander pattern 12 grows horizontally by an amount 2*d2 per loop. However, it also shrinks vertically, by an amount h2. Thus, the vertical growth of the vertical meander pattern 11 compensates, at least partially, for the vertical shrinkage of the horizontal meander pattern 12, and vice versa. It is noted that the end portions of any stent are only partially compensated and therefore, may shrink somewhat.
  • It will be appreciated that the two orthogonal meander patterns [0031] 11 and 12 and the compensation they provide to each other provides flexibility to the unexpended stent of FIG. 1 However, when the stent is expanded, the changes in each of loops 14 and 16 provide rigidity to the resultant stent and thus, enable the stent to maintain a blood vessel at a desired inner diameter.
  • The stent of the present invention can be manufactured from flat metal which is etched into the pattern of FIG. 2. The etched metal is then bent to form the tube [0032] 30. Alternatively, the pattern of FIG. 2 can be manufactured from welded or twisted wire.
  • It will be appreciated that the stent of the present invention can be made from metal and/or wire. Additionally, it can be plated with a protective material, embedded with a medicine, and/or covered with a material which can fill in the spaces [0033] 42 and 44.
  • It will be appreciated that the present invention encompasses all stents manufactured with a pattern formed of two meander patterns, orthogonal or otherwise. Another exemplary pattern, also with orthogonal meander patterns, is provided herein wherein FIG. 6 is a schematic version and FIG. 7 is a more rounded version. FIG. 8 shows the pattern of FIG. 7 in an expanded format. The pattern of FIGS. 6 and 7 is similar to that shown in FIG. 2 except that it has more horizontal meander patterns [0034] 12 and they are of one kind, rather than being even and odd as in FIG. 2.
  • As can be seen in both FIGS. 6 and 7, there are two types of vertical meander patterns [0035] 11 e and 11 o which are 180° out of phase with each other. The horizontal meander patterns 12 connect with every line 15 of vertical meander pattern 11 e.
  • FIG. 8 illustrates the pattern of FIG. 7 is an expanded format. Since there are no even and odd horizontal meander patterns, in the expanded format of FIG. 8, there are no large and small spaces. Instead, all spaces are of the same size, i.e., the stent is comprised of a plurality of spaces or cells [0036] 50 defining a uniform cellular structure.
  • As shown in FIGS. 3, 7 and [0037] 8, Applicants' invention can also be described as an expandable stent defining a longitudinal aperture 80 having a longitudinal axis or extension 79 and a circumferential axis or extension 105, including a plurality of flexible connected cells 50 with each of the flexible cells 50 having a first longitudinal end 77 and a second longitudinal end 78 Each cell 50 also is provided with a first longitudinal apex 100 disposed at the first longitudinal end 77 and a second longitudinal apex 104 disposed at the second longitudinal end 78. Each cell 50 also includes a first member 51 having a longitudinal component having a first end 52 and a second end 53; a second member 54 having a longitudinal component having a first end 55 and a second end 56; a third member 57 having a longitudinal component having a first end 58 and a second end 59; and a fourth member 60 having a longitudinal component having a first end 61 and a second end 62. The stent also includes a first loop 63 defining a first angle 64 disposed between the first end 52 of the first member 51 and the first end 55 of the second member 54.
  • A second loop [0038] 65 defining a second angle 66 is disposed between the second end 59 of the third member 57 and the second end 62 of the fourth member 60 and is disposed generally opposite to the first loop 63. A first flexible compensating member or flexible link 67 having a first end 68 and a second end 69 is disposed between the first member 51 and the third member 57 with the first end 68 of the first flexible compensating member or flexible link 67 communicating with the second end 53 of the first member 51 and the second end 69 of the first flexible compensating member or flexible link 67 communicating with the first end 58 of the third member 57. The first end 68 and the second end 69 are disposed a variable longitudinal distance 70 from each other.
  • A second flexible compensating member [0039] 71 having a first end 72 and a second end 73 is disposed between the second member 54 and the fourth member 60. The first end 72 of the second flexible compensating member or flexible link 71 communicates with the second end 56 of the second member 54 and the second end 73 of the second flexible compensating member or flexible link 71 communicates with the first end 61 of the fourth member 60. The first end 72 and the second end 73 are disposed a variable longitudinal distance 74 from each other.
  • In a preferred embodiment, the first and second flexible compensating member or flexible links [0040] 67 and 71 are arcuate. The fist and second flexible compensating member or flexible links 67 and 71 are differentially extendable or compressible when the stent is bent in a curved direction away from the longitudinal axis 79 of the aperture 80. (Shown in FIG. 3.) The first member 51, second member 54, third member 57, and fourth member 60 and the first loop 63 and the second loop 65 and the first flexible compensating member or flexible link 67 and the second flexible compensating member or flexible link 71 are disposed so that as the stent is expanded the distance between the first flexible compensating member or flexible link 67 and the second flexible compensating member or flexible link 71 increases and the longitudinal component of the first member 51, second member 54, third member 57 and fourth member 60 decreases while the first loop 63 and the second loop 65 remain generally opposite to one another, the ends 68 and 69 of the first flexible compensating member or flexible link 67 and the ends 72 and 73 of the second flexible compensating member or flexible link 71 open so as to increase the variable longitudinal distance 70 between the first end 68 and the second end 69 of the first flexible compensating member or flexible link 67 and so as to increase the variable longitudinal distance 74 between the first end 72 and the second end 73 of the second flexible compensating member or flexible link 71. This compensates for the decreasing of the longitudinal component of the first member 51, second member 54, third member 57, and fourth member 60 and substantially lessens the foreshortening of the stent upon its expansion.
  • In a preferred embodiment, and as shown in FIG. 5A, the flexible compensating member or flexible links [0041] 67 and 71 compensate in an amount that is substantially equal to the amount that the stent foreshortens. As shown in FIGS. 7 and 8, the first flexible compensating member or flexible link 67 and the second flexible compensating member or flexible link 71 in each cell 50 of each row or band of cells 101, 102 and 103, serve to flexibly connect other cells 50 in adjacent rows or bands 102, 103, and 104 which themselves have first and second compensating members 67 and 71.
  • As shown in FIG. 7, the first flexible compensating member or flexible links [0042] 67 and 71 in row or band 101 serve to flexibly connect the cells 50 in adjacent rows or bands 102 and 103. As shown in FIGS. 7 and 8, a portion of the flexible member 67 or 71 disposed between the first ends 68 and 72 and the second ends 69 and 73 may be provided with a width that is smaller than the width of the apices 100 and 104 to which they are attached.
  • It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather the scope of the present invention is defined by the claims which follow: [0043]

Claims (41)

What is claimed is:
1. A stent for implanting in the body to hold open a blood vessel, comprising:
a. a body-compatible metal mesh defining a tube having adjacent contiguous cells, the cells having walls which are also the walls of adjacent cells, each of the plurality of cells including a pair of facing loops, each facing loop having a curved apex generally aligned along the longitudinal axis, and each facing loop having a first end and a second end that are generally aligned along the circumferential axis, each of the facing loops adapted to open further upon radial expansion of the stent which tends to foreshorten the stent longitudinally,
b. each of the plurality of cells further including a pair of curved flexible links which connect the adjacent ends of the pair of facing loops to complete each of the plurality of cells, the pair of curved flexible links made of a metal which, upon expansion of the stent, bend to substantially offset foreshortening along the longitudinal axis, and
c. said pair of facing loops and said curved flexible links disposed and adapted to cooperate so that the tube, when unexpended, can flex as it is moved through curved blood vessels to a site where it is to be expanded and so that, when the stent is expanded in a curved vessel, at that site, as compared to each other, cells on the outside of the curve are open in length, but narrow in width as compared to cells on the inside of the curve which are short in length but increased in width.
2. A stent according to claim 1 wherein on the outside of the curve, the curved flexible links are open and the facing loops are closed as compared to the inside of the curve, where the flexible links are closed and the facing loops are open.
3. A stent according to claim 1 wherein compensation, which occurs when cells on the outside of the curve are open in length, but narrower in width as compared to cells on the inside of the curve, which are shorter in length but increased in width, results in a more constant density of stent element area between the inside and the outside of the curve than would otherwise occur.
4. A stent according to claim 1 wherein compensation, which occurs when cells on the outside of the curve are open in length, but narrower in width as compared to cells on the inside of the curve, which are shorter in length but increased in width, results in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur.
5. A stent according to claim 3 wherein said stent is coated with a medicine and said compensation results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
6. A stent according to claim 4 wherein said stent is coated with a medicine and said compensation results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
7. The stent of claim 1, positioned on a balloon which upon expansion causes the stent to expand to hold open the blood vessel.
8. The expanded stent of claim 1, in which the expanded stent has approximately the same longitudinal length as the stent had prior to expansion.
9. A balloon-expandable stent defining a longitudinal aperture, said stent consisting essentially of:
a. a plurality of flexible connected cells, each of said flexible cells comprising:
i. a first member having a longitudinal component having a first end and a second end;
ii. a second member having a longitudinal component having a first end and
iii. a third member having a longitudinal component having a first end and a second end;
iv. a fourth member having a longitudinal component having a first end and a second end;
v. a first loop defining a first angle disposed between said first end of said first member and said first end of said second member;
vi. a second loop defining a second angle disposed between said second end of said third member and said second end of said fourth member, and disposed generally opposite to said first loop so that said first angle and said second angle open toward each other,
vii. a first flexible compensating member having a first end and a second end disposed between said first member and said third member, said first end of said first flexible compensating member communicating with said second end of said first member and said second end of said first flexible compensating member communicating with said first end of said third member, said first and said second ends disposed a variable longitudinal distance from each other;
viii. a second flexible compensating member having a first end and a second end disposed between said second member and said fourth member, said first end of said second flexible compensating member communicating with said second end of said second member and said second end of said second flexible compensating member communicating with said first end of said fourth member, said first and said second ends disposed a variable longitudinal distance from each other, said first and said second flexible compensating member differentially extendable or compressible when said stent is bent in a curved direction away from the longitudinal axis of said aperture; and
ix. said first, said second, said third, and said fourth members and said first and said second loops, and said first and said second flexible compensating member disposed so that as said stent is balloon-expanded from a delivery diameter to a deployment diameter the distance between said first and said second flexible compensating member increases and the longitudinal component of said first, second, third and fourth members decreases while said first and said second loops remain generally opposite to one another, the ends of said first and said second flexible compensating member open so as to increase said variable longitudinal distance between said first and said second ends of said first flexible compensating member and so as to increase said variable longitudinal distance between said first and said second ends of said second flexible compensating member so as to compensate for the decreasing of the longitudinal component of said first, second, third, and fourth members and substantially lessen the foreshortening of said stent upon its expansion, and
b. said first and second loops and said flexible compensating member disposed and adapted to cooperate so that the tube, when unexpended, can flex as it is moved through curved blood vessels to a site where it is to be expanded and so that, when the stent is expanded in a curved vessel, at that site, as compared to each other, cells on the outside of the curve are open in length, but narrow in width as compared to cells on the inside of the curve which are short in length but increased in width.
10. A stent according to claim 9 wherein on the outside of the curve, the flexible compensating members open up and the first and second loops close down, and on the inside of the curve, the flexible compensating members close down and the first and second loops open up.
11. A stent according to claim 9 wherein compensation, which occurs when cells on the outside of the curve open in length, but narrow in width and cells on the inside of the curve shorten in length but thicken in width, results in a more constant density of stent element area between the inside and the outside of the curve than would otherwise occur.
12. A stent according to claim 9 wherein compensation, which occurs when cells on the outside of the curve open in length, but narrow in width and cells on the inside of the curve shorten in length but thicken in width, results in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur.
13. A stent according to claim 12 wherein said stent is coated with a medicine and said compensation results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area.
14. A stent according to claim 11 wherein said stent is coated with a medicine and said compensation results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area.
15. A balloon-expandable stent, consisting substantially of:
a. flexible cells disposed about the circumference of the stent, each of said cells having a first longitudinal end and a second longitudinal end and an upper end and a lower end, each of said cells consisting essentially of
i. a first pair of members connected by an area of inflection generally disposed at said first longitudinal end of each of said cells;
ii. a second pair of members connected by an area of inflection generally disposed at said second longitudinal end of each of said cells; and
iii. a first flexible compensating member disposed between said first and second pair of members at said upper end of each of said cells;
iv. a second flexible compensating member disposed between said first and second pair of members at said lower end of each of said cells;
b. wherein upon bending of the stent the flexible compensating members on the outside of the bend lengthen in the longitudinal direction and the flexible compensating members on the inside of the bend shorten in the longitudinal direction;
c. wherein upon expansion of the stent by a balloon from a delivery diameter to a deployment diameter, the flexible compensating members lengthen in the longitudinal direction to compensate for the tendency of the stent to foreshorten, and
d. wherein, when the expanded stent is in a curved lumen, on the outside of the bend, the first and second pairs of members come closer together in the circumferential direction, as compared to the inside of the bend, where the first and second pairs of members separate in the circumferential direction.
16. A stent according to claim 15 wherein compensation which occurs when the first and second pairs of members come closer together in the circumferential direction on the outside and the first and second pairs of members separate in the circumferential direction on the inside compensates respectively for the shortening and lengthening of the flexible compensating members to result in a more constant density of stent element area between the inside and the outside of the curve than would otherwise occur.
17. A stent according to claim 15 wherein compensation which occurs when the first and second pairs of members come closer together in the circumferential direction on the outside and the first and second pairs of members separate in the circumferential direction on the inside compensates respectively for the shortening and lengthening of the flexible compensating members to result in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur.
18. A stent according to claim 16 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
19. A stent according to claim 17 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
20. A flexible, balloon-expandable stent having a longitudinal axis, consisting essentially of
a. a plurality of flexible cells, each of said flexible cells consisting essentially of
i. a first pair of members connected by an area of inflection defining a right-facing loop;
ii. a second pair of members connected by an area of inflection defining a left-facing loop that faces the right-facing loop;
iii. a first flexible link connecting the top of said first pair of members to the top of said second pair of members; and
iv. a second flexible link connecting the bottom of said first pair of members to the bottom of said second pair of members;
b. wherein said flexible cells are adapted so that said stent prior to expansion is bendable in substantially any direction without affecting the structural or functional integrity of said stent,
c. wherein said flexible cells are adapted so that upon the expansion of said stent by a balloon from a delivery diameter to a deployment diameter, said first and second pairs of members shorten in a longitudinal direction and said flexible links lengthen in the longitudinal direction to compensate for said first and second pairs of members shortening in the longitudinal direction and for the tendency of said stent to foreshorten, and
d. wherein said flexible cells are further adapted to impart rigidity to said stent in an amount sufficient to support a lumen when said stent is expanded; and
e. wherein said right and left facing loops and said flexible links are disposed and adapted to cooperate so that the tube, when unexpended, can flex as it is moved through curved blood vessels to a site where it is to be expanded and so that, when the stent is expanded in a curved vessel, at that site, as compared to each other, cells on the outside of the curve are open in length, but narrow in width as compared to cells on the inside of the curve which are short in length but increased in width.
21. A stent according to claim 20, wherein on the outside of the curve, the curved flexible links open up and the loops close down, and on the inside of the curve, the flexible links close down and the loops open up.
22. A stent according to claim 20 wherein compensation, which occurs when cells on the outside of the curve open in length, but narrow in width and cells on the inside of the curve shorten in length but thicken in width, results in a more constant density of stent element area between the inside and the outside of the curve than would otherwise occur.
23. A stent according to claim 20 wherein compensation, which occurs when cells on the outside of the curve open in length, but narrow in width and cells on the inside of the curve shorten in length but thicken in width, results in a more constant stent cell area between the inside and the outside of the curve than would otherwise occur.
24. A stent according to claim 22 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area.
25. A stent according to claim 23 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area.
26. An expandable stent for supporting a vessel, wherein in the expanded and deployed state, the stent consists of
a. first meander patterns having loops, the first meander patterns having axes extending circumferentially; and
b. second meander patterns having loops, the second meander patterns having axes extending horizontally,
c. wherein the first and second meander patterns are intertwined to form a tubular structure;
d. wherein the first meander patterns are connected to the second meander patterns so as to leave at least one loop of the second meander patterns between each pair of adjacent first meander patterns;
e. wherein the second meander patterns are connected to the first meander patterns so as to leave two loops of the first meander patterns between each pair of adjacent second meander patterns, and
f. wherein said first and second meander patterns are adapted to cooperate so that, when the expanded stent is in a curved vessel, on the outside of the curve, a circumferential shrinkage and horizontal growth of the loops in said first meander pattern substantially compensates for a horizontal growth and circumferential compression of the loops in said second meander pattern and vice versa on the inside of the curve.
27. A stent according to claim 26, wherein on the outside of the curve, the loops in said second meander pattern open up and the loops in the first meander pattern close down, and on the inside of the curve, the loops in said second meander pattern close down and the loops in the first meander pattern open up.
28. A stent according to claim 26 wherein the compensation maintains a density of stent element area which is more constant on the inside and on the outside of the curve than it would without the compensation.
29. A stent according to claim 26 wherein the compensation maintains a stent area which is more constant on the inside and on the outside of the curve than it would without the compensation.
30. A stent according to claim 28 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
31. A stent according to claim 29 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
32. The stent according to claim 26, wherein the shape of the loops provides rigidity to the stent to enable the stent to maintain a blood vessel at a desired inner diameter.
33. The stent according to claim 26, wherein the stent defines a plurality of enclosed spaces, with each longitudinal end of the enclosed space being formed by loops of the first meander pattern.
34. The stent according to claim 33 wherein the enclosed spaces are substantially the same size.
35. A stent formed of a tube having a patterned shape consisting of:
a. even first meander patterns having axes extending [in a first direction] circumferentially,
b. odd first meander patterns having axes extending [in a first direction] circumferentially, wherein the odd first meander patterns are 180° out of phase with the even first meander patterns and occur between every two even first meander patterns;
c. second meander patterns having axes extending [in a second direction different from the first direction] horizontally, [and] the second meander patterns [are] intertwined with the even and odd first meander patterns to form a generally uniform distributed structure;
d. wherein the first and second meander patterns have loops,
e. wherein the even and odd first meander patterns are interconnected to leave a portion of the second meander pattern between adjacent even and odd first meander patterns,
f. wherein the portion of the second meander pattern between adjacent even and odd first meander patterns adapted to compensate for the tendency of the loops of the first meander to foreshorten when the stent is expanded,
g. wherein the second meanders are interconnected to leave two loops of the first meander pattern between each pair of second meander pattern, and
h. wherein the portion of the second meander pattern between adjacent even and odd first meander patterns and loops of the first meander pattern are adapted to cooperate so that, when the expanded stent is in a curved vessel, on the outside of the curve, a circumferential shrinkage and horizontal growth of the loops in said first meander pattern substantially compensates for a horizontal growth and circumferential compression of the portion of the second meander pattern between adjacent even and odd first meander patterns and vice versa on the inside of the curve.
36. A stent according to claim 35, wherein on the outside of the curve, the portion of the second meander pattern between adjacent even and odd first meander patterns includes at least one loop and the loops in said second meander pattern open up and the loops in the first meander pattern close down, and on the inside of the curve, the loops in said second meander pattern close down and the loops in the first meander pattern open up.
37. A stent according to claim 35 wherein the compensation maintains a density of stent element area which is more constant on the inside and on the outside of the curve than it would without the compensation.
38. A stent according to claim 35 wherein the compensation maintains a stent area which is more constant on the inside and on the outside of the curve than it would without the compensation.
39. A stent according to claim 37 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
40. A stent according to claim 38 wherein said stent is coated with a medicine and said more constant density of stent elements results in a more even dose being applied to the inside wall of the lumen, avoiding the possibility that a toxic dose is supplied at one area while a less than effective dose is applied to another area
41. The stent according to claim 35, wherein changes in the shape of the loops provide rigidity to the stent upon expansion to enable the stent to maintain a blood vessel at a desired inner diameter.
US10/644,465 1994-03-17 2003-08-20 Flexible expandable stent Abandoned US20040102835A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US08/213,272 US5449373A (en) 1994-03-17 1994-03-17 Articulated stent
US28218194A true 1994-07-28 1994-07-28
US08/457,354 US5733303A (en) 1994-03-17 1995-05-31 Flexible expandable stent
US78246797A true 1997-01-10 1997-01-10
US08/881,594 US5843120A (en) 1994-03-17 1997-06-24 Flexible-expandable stent
US09/026,099 US5972018A (en) 1994-03-17 1998-02-19 Flexible expandable stent
US09/337,629 US6461381B2 (en) 1994-03-17 1999-06-21 Flexible expandable stent
US09/971,616 US6635084B2 (en) 1994-03-17 2001-10-09 Flexible expandable stent
US10/644,465 US20040102835A1 (en) 1994-03-17 2003-08-20 Flexible expandable stent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/644,465 US20040102835A1 (en) 1994-03-17 2003-08-20 Flexible expandable stent
US11/850,078 US20070299507A1 (en) 1994-03-17 2007-09-05 Flexible Expandable Stent
US12/173,353 US20080269873A1 (en) 1994-03-17 2008-07-15 Flexible expandable stent

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/337,629 Continuation US6461381B2 (en) 1994-03-17 1999-06-21 Flexible expandable stent
US09/971,616 Continuation US6635084B2 (en) 1994-03-17 2001-10-09 Flexible expandable stent

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/850,078 Continuation US20070299507A1 (en) 1994-03-17 2007-09-05 Flexible Expandable Stent
US12/173,353 Continuation US20080269873A1 (en) 1994-03-17 2008-07-15 Flexible expandable stent

Publications (1)

Publication Number Publication Date
US20040102835A1 true US20040102835A1 (en) 2004-05-27

Family

ID=27556073

Family Applications (6)

Application Number Title Priority Date Filing Date
US09/337,629 Expired - Lifetime US6461381B2 (en) 1994-03-17 1999-06-21 Flexible expandable stent
US09/489,362 Expired - Lifetime US6443982B1 (en) 1994-03-17 2000-01-21 Flexible expandable stent
US09/971,616 Expired - Fee Related US6635084B2 (en) 1994-03-17 2001-10-09 Flexible expandable stent
US10/644,465 Abandoned US20040102835A1 (en) 1994-03-17 2003-08-20 Flexible expandable stent
US11/850,078 Abandoned US20070299507A1 (en) 1994-03-17 2007-09-05 Flexible Expandable Stent
US12/173,353 Abandoned US20080269873A1 (en) 1994-03-17 2008-07-15 Flexible expandable stent

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/337,629 Expired - Lifetime US6461381B2 (en) 1994-03-17 1999-06-21 Flexible expandable stent
US09/489,362 Expired - Lifetime US6443982B1 (en) 1994-03-17 2000-01-21 Flexible expandable stent
US09/971,616 Expired - Fee Related US6635084B2 (en) 1994-03-17 2001-10-09 Flexible expandable stent

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/850,078 Abandoned US20070299507A1 (en) 1994-03-17 2007-09-05 Flexible Expandable Stent
US12/173,353 Abandoned US20080269873A1 (en) 1994-03-17 2008-07-15 Flexible expandable stent

Country Status (1)

Country Link
US (6) US6461381B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10271977B2 (en) 2017-09-22 2019-04-30 Vesper Medical, Inc. Hybrid stent

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6461381B2 (en) * 1994-03-17 2002-10-08 Medinol, Ltd. Flexible expandable stent
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US7988720B2 (en) 2006-09-12 2011-08-02 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
JP4636634B2 (en) * 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Intravascular stent
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US20040267350A1 (en) * 2002-10-30 2004-12-30 Roubin Gary S. Non-foreshortening intraluminal prosthesis
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US7329277B2 (en) * 1997-06-13 2008-02-12 Orbusneich Medical, Inc. Stent having helical elements
EP0884029B1 (en) 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US7887578B2 (en) * 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US6423055B1 (en) * 1999-07-14 2002-07-23 Cardiofocus, Inc. Phototherapeutic wave guide apparatus
US20010047200A1 (en) * 1999-10-13 2001-11-29 Raymond Sun Non-foreshortening intraluminal prosthesis
EP1132058A1 (en) * 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
US7766956B2 (en) 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
EP1372531A2 (en) * 2001-03-30 2004-01-02 Terumo Kabushiki Kaisha Stent cover and stent
US20050021123A1 (en) 2001-04-30 2005-01-27 Jurgen Dorn Variable speed self-expanding stent delivery system and luer locking connector
US6997944B2 (en) * 2001-08-13 2006-02-14 Advanced Cardiovascular Systems, Inc. Apparatus and method for decreasing stent gap size
EP1516600B1 (en) * 2001-09-18 2007-03-14 Abbott Laboratories Vascular Enterprises Limited Stent
US7637935B2 (en) * 2002-05-06 2009-12-29 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
US7625398B2 (en) 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
US7625401B2 (en) 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
EP1503700B1 (en) 2002-05-08 2012-09-26 Abbott Laboratories Endoprosthesis having foot extensions
US20040054398A1 (en) * 2002-09-13 2004-03-18 Cully Edward H. Stent device with multiple helix construction
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US20040158314A1 (en) * 2002-12-24 2004-08-12 Novostent Corporation Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use
US20050033410A1 (en) * 2002-12-24 2005-02-10 Novostent Corporation Vascular prothesis having flexible configuration
US7846198B2 (en) * 2002-12-24 2010-12-07 Novostent Corporation Vascular prosthesis and methods of use
US20050165469A1 (en) * 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US20040160685A1 (en) * 2003-01-27 2004-08-19 Everardo Daniel Faires Quiros Lower rear view mirror (LRVM for short)
US7179286B2 (en) * 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
EP2364676B1 (en) 2005-06-30 2018-12-19 Abbott Laboratories Endoprosthesis having foot extensions
US8999364B2 (en) 2004-06-15 2015-04-07 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US20050060020A1 (en) * 2003-09-17 2005-03-17 Scimed Life Systems, Inc. Covered stent with biologically active material
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
WO2005081655A2 (en) * 2004-02-17 2005-09-09 The Children's Hospital Of Philadelphia Gene and cell delivery self expanding polymer stents
US9707071B2 (en) * 2004-11-24 2017-07-18 Contego Medical Llc Percutaneous transluminal angioplasty device with integral embolic filter
DE102004045226B4 (en) * 2004-09-17 2008-01-17 Optiray Medizintechnik Gmbh support prosthesis
US7731654B2 (en) 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
US8961586B2 (en) * 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
US20100324664A1 (en) * 2006-10-18 2010-12-23 Asher Holzer Bifurcated Stent Assemblies
WO2006126182A2 (en) 2005-05-24 2006-11-30 Inspire M.D Ltd. Stent apparatuses for treatment via body lumens and methods of use
JP2009504345A (en) 2005-08-17 2009-02-05 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Variable speed stent delivery system
EP2727564A1 (en) 2006-01-13 2014-05-07 C. R. Bard, Inc. Stent delivery system
KR100795125B1 (en) 2006-07-31 2008-01-17 연세대학교 산학협력단 Coronary artery stent
GB0615658D0 (en) 2006-08-07 2006-09-13 Angiomed Ag Hand-held actuator device
US8043323B2 (en) * 2006-10-18 2011-10-25 Inspiremd Ltd. In vivo filter assembly
EP2083902B1 (en) * 2006-10-18 2017-08-30 Inspiremd Ltd. Filter assemblies
EP2076212B1 (en) * 2006-10-18 2017-03-29 Inspiremd Ltd. Knitted stent jackets
WO2008062414A2 (en) 2006-11-22 2008-05-29 Inspiremd Ltd. Optimized stent jacket
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US20080300671A1 (en) * 2007-06-04 2008-12-04 Gil Vardi Stent having high expansion ratio
GB0713497D0 (en) 2007-07-11 2007-08-22 Angiomed Ag Device for catheter sheath retraction
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US20090157161A1 (en) * 2007-10-24 2009-06-18 Edwards Lifesciences Corporation Percutaneous Nitinol Stent Extraction Device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
JP5744736B2 (en) * 2008-09-15 2015-07-08 アイーグ エービー Devices for medical use for temporary occlusion of the opening in the lumen of the body, methods, and systems
US8808347B2 (en) 2008-09-25 2014-08-19 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
CA2739007C (en) 2008-09-25 2017-10-31 Advanced Bifurcation Systems, Inc. Partially crimped stent
US9510930B2 (en) 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
EP2549952A4 (en) 2010-03-24 2017-01-04 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
EP2549958A4 (en) 2010-03-24 2016-09-14 Advanced Bifurcation Systems Inc Methods and systems for treating a bifurcation with provisional side branch stenting
GB201017834D0 (en) 2010-10-21 2010-12-01 Angiomed Ag System to deliver a bodily implant
US9144268B2 (en) 2010-11-02 2015-09-29 Nike, Inc. Strand-wound bladder
WO2012109365A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation with a fully crimped stent
CA2826760A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9482604B2 (en) * 2012-04-17 2016-11-01 Northeastern University Equi-biaxial membrane stretcher
BR112014028242A2 (en) 2012-05-14 2017-06-27 Bard Inc C R uniformly expandable stent
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US20140277383A1 (en) * 2013-03-15 2014-09-18 Contego Medical, Llc Expandable stent having a constant length
US9375810B2 (en) 2014-01-24 2016-06-28 Q3 Medical Devices Limited Bidirectional stent and method of use thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5019090A (en) 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5019085A (en) 1988-10-25 1991-05-28 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
CA2026604A1 (en) 1989-10-02 1991-04-03 Rodney G. Wolff Articulated stent
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5158548A (en) 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
DE69118083T2 (en) 1990-10-09 1996-08-22 Cook Inc Percutaneous stent assembly
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
EP0506918B1 (en) 1990-10-18 1996-01-03 SONG, Ho Young Self-expanding endovascular stent
US5161547A (en) 1990-11-28 1992-11-10 Numed, Inc. Method of forming an intravascular radially expandable stent
FR2671280B1 (en) 1991-01-03 1993-03-05 Sgro Jean Claude Self-expanding stent permanently elastic, low-shortening material and its application.
US5116365A (en) 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5314472A (en) 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
FR2683449A1 (en) 1991-11-08 1993-05-14 Cardon Alain Stent for transluminal implantation.
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5405377A (en) 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5268534A (en) 1992-03-27 1993-12-07 Gailey Brian L Braided flattened tube conductor
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
JPH07509633A (en) 1992-08-06 1995-10-26
CA2112845A1 (en) 1993-01-06 1994-07-07 Anthony S. Miksza Stent
US5441515A (en) 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and a method for manufacturing the same
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
DE69502746D1 (en) 1994-02-25 1998-07-09 Fischell Robert Stent having a plurality of closed circular structures
US6461381B2 (en) * 1994-03-17 2002-10-08 Medinol, Ltd. Flexible expandable stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
DE69531239T2 (en) 1994-04-01 2004-04-22 Prograft Medical, Inc., Palo Alto Selbstausdehnbarer stent and stent-graft transplant
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
DE69507800T2 (en) 1994-05-19 1999-07-22 Scimed Life Systems Inc Improved tissue supporting devices
US5514093A (en) 1994-05-19 1996-05-07 Scimed Life Systems, Inc. Variable length balloon dilatation catheter
EP1110515B1 (en) 1995-04-26 2006-03-22 Medinol Limited Articulated stent
US5593442A (en) 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5836964A (en) * 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
DE29702671U1 (en) 1997-02-17 1997-04-10 Jomed Implantate Gmbh stent
US6461380B1 (en) * 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10271977B2 (en) 2017-09-22 2019-04-30 Vesper Medical, Inc. Hybrid stent

Also Published As

Publication number Publication date
US20080269873A1 (en) 2008-10-30
US6461381B2 (en) 2002-10-08
US20020010506A1 (en) 2002-01-24
US6635084B2 (en) 2003-10-21
US20010018595A1 (en) 2001-08-30
US6443982B1 (en) 2002-09-03
US20070299507A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
US5092877A (en) Radially expandable endoprosthesis
EP0955950B1 (en) Flat wire stent
EP1158934B1 (en) Stent with varying strut geometry
US8419786B2 (en) Self-expanding stent
US6251134B1 (en) Stent with high longitudinal flexibility
US5938682A (en) Axially flexible stent
CA2349384C (en) Serpentine coiled ladder stent
EP1346706B1 (en) Stent with enhanced crossability
US6331189B1 (en) Flexible medical stent
EP1703859B1 (en) Stent to be deployed on a bend
EP1616534B1 (en) Intraluminal stent with expandable unit cell
EP2204142B1 (en) Longitudinally flexible expandable stent
US6083259A (en) Axially non-contracting flexible radially expandable stent
US7611531B2 (en) Stent
US6022370A (en) Expandable stent
US6416538B1 (en) Stent configurations
EP0879027B1 (en) Axially flexible stent
US6471720B1 (en) Stent configurations
US8721705B2 (en) Non-foreshortening intraluminal prosthesis
CA2619573C (en) Longitudinally flexible stent
US6475237B2 (en) Intravascular hinge stent
CA2374090C (en) Flexible stent and method of manufacture
US6610086B1 (en) Radially expandable stent IV
US5019090A (en) Radially expandable endoprosthesis and the like
CA2270991C (en) Radially expandable axially non-contracting surgical stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDINOL, LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ISRAEL, HENRY MARSHALL;PINCHASIK, GREGORY;REEL/FRAME:014859/0324

Effective date: 20031228